OT
Omega Therapeutics
Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.
Rate
About
Omega Therapeutics is a biotechnology company focused on developing a novel class of therapeutics called Epigenomic Controllers (ECs). These ECs are designed to precisely modulate gene expression by targeting specific epigenetic marks, offering a new approach to treating a wide range of diseases.
Technology stack
detected 2026-06-06Est. monthly stack spend~$70/mo
Email
Microsoft 365
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Omega Therapeutics do?
Omega Therapeutics is a biotechnology company focused on developing a novel class of therapeutics called Epigenomic Controllers (ECs). These ECs are designed to precisely modulate gene expression by targeting specific epigenetic marks, offering a new approach to treating a wide range of diseases.
Where is Omega Therapeutics headquartered?
Omega Therapeutics is headquartered in Cambridge, United States.
When was Omega Therapeutics founded?
Omega Therapeutics was founded in 2017.
What industry does Omega Therapeutics operate in?
Omega Therapeutics operates in Biotech, Drug Discovery, Genomics, Epigenetic Reprogramming, Precision Medicine, Therapeutics.
What is Omega Therapeutics's current status?
Omega Therapeutics's current operating status is: Inactive.